Veradigm Inc. and its top executives allegedly misled investors about the company’s revenue figures and demand for more than two years, according to a shareholder class action complaint.
The healthcare technology company allegedly failed to maintain effective internal controls over its financial reporting or to comply with appropriate revenue recognition practices, ultimately receiving a delisting notice from Nasdaq due to the compliance failures, according to the complaint filed Nov. 22 in US District Court for the Northern District of Illinois.
Veradigm, formerly Allscripts Healthcare Solutions Inc., overstated its historical revenues by at least $20 million, artificially inflated its revenue by ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.